Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis.

Xiao J, Chang S, Chen S.

Fertil Steril. 2013 Dec;100(6):1594-601.e1-9. doi: 10.1016/j.fertnstert.2013.08.024. Epub 2013 Sep 19. Review.

PMID:
24055048
2.

Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.

Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger D, Bern O, Raziel A.

Fertil Steril. 2008 Oct;90(4):1087-93. Epub 2007 Nov 26.

PMID:
18023439
3.

Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis.

Xiao J, Chen S, Zhang C, Chang S.

Gynecol Endocrinol. 2013 Mar;29(3):187-91. doi: 10.3109/09513590.2012.736561. Epub 2012 Nov 30. Review.

PMID:
23194095
4.

Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.

Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM.

Fertil Steril. 2013 Nov;100(5):1296-302. doi: 10.1016/j.fertnstert.2013.07.1976. Epub 2013 Aug 28.

PMID:
23993928
5.

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.

Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.

Fertil Steril. 2009 Feb;91(2):365-71. doi: 10.1016/j.fertnstert.2007.11.049. Epub 2008 Mar 25.

PMID:
18367175
6.

Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial.

Sunkara SK, Coomarasamy A, Faris R, Braude P, Khalaf Y.

Fertil Steril. 2014 Jan;101(1):147-53. doi: 10.1016/j.fertnstert.2013.09.035. Epub 2013 Nov 1. Erratum in: Fertil Steril. 2014 Jun;101(6):1791.

PMID:
24188873
7.

Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis.

Xiao JS, Su CM, Zeng XT.

PLoS One. 2014 Sep 12;9(9):e106854. doi: 10.1371/journal.pone.0106854. eCollection 2014 Sep 12. Review.

8.

Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.

Pu D, Wu J, Liu J.

Hum Reprod. 2011 Oct;26(10):2742-9. doi: 10.1093/humrep/der240. Epub 2011 Jul 21. Erratum in: Hum Reprod. 2012 Apr;27(4):1230.

PMID:
21778283
9.

A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.

Berin I, Stein DE, Keltz MD.

Fertil Steril. 2010 Feb;93(2):360-3. doi: 10.1016/j.fertnstert.2008.11.007. Epub 2009 Jan 7.

PMID:
19131055
10.

In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.

Farhi J, Ben-Haroush A, Lande Y, Sapir O, Pinkas H, Fisch B.

Fertil Steril. 2009 Feb;91(2):377-82. doi: 10.1016/j.fertnstert.2007.11.086. Epub 2008 Mar 5.

PMID:
18321490
11.

Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials.

Griesinger G, Mannaerts B, Andersen CY, Witjes H, Kolibianakis EM, Gordon K.

Fertil Steril. 2013 Dec;100(6):1622-8.e1-3. doi: 10.1016/j.fertnstert.2013.08.045. Epub 2013 Sep 29.

PMID:
24083873
12.

Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.

Griffin D, Feinn R, Engmann L, Nulsen J, Budinetz T, Benadiva C.

Fertil Steril. 2014 Aug;102(2):405-9. doi: 10.1016/j.fertnstert.2014.04.028. Epub 2014 May 17.

PMID:
24842671
13.
14.

Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis.

Sunkara SK, Tuthill J, Khairy M, El-Toukhy T, Coomarasamy A, Khalaf Y, Braude P.

Reprod Biomed Online. 2007 Nov;15(5):539-46. Review.

PMID:
18028745
15.

GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis.

Franco JG Jr, Baruffi RL, Mauri AL, Petersen CG, Felipe V, Cornicelli J, Cavagna M, Oliveira JB.

Reprod Biomed Online. 2006 Nov;13(5):618-27.

PMID:
17169170
16.
17.

Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?

Ren J, Sha A, Han D, Li P, Geng J, Ma C.

Fertil Steril. 2014 Jul;102(1):75-81. doi: 10.1016/j.fertnstert.2014.03.030. Epub 2014 Apr 18.

PMID:
24746740
18.

Comparison of different stimulation protocols efficacy in poor responders undergoing IVF: a retrospective study.

Madani T, Ashrafi M, Yeganeh LM.

Gynecol Endocrinol. 2012 Feb;28(2):102-5. doi: 10.3109/09513590.2011.579206.

PMID:
22263965
19.

Substituting HCG with GnRH agonist to trigger final follicular maturation--a retrospective comparison of three different ovarian stimulation protocols.

Orvieto R, Rabinson J, Meltzer S, Zohav E, Anteby E, Homburg R.

Reprod Biomed Online. 2006 Aug;13(2):198-201.

PMID:
16895632
20.

GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.

Orvieto R, Nahum R, Zohav E, Liberty G, Anteby EY, Meltcer S.

Gynecol Endocrinol. 2013 Jan;29(1):51-3. doi: 10.3109/09513590.2012.705376. Epub 2012 Aug 3.

PMID:
22857268

Supplemental Content

Support Center